George S. Alexopoulos

George S. Alexopoulos

Auto-generated profile, based on publicly available information

George S. Alexopoulos

Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, White Plains, USA

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1988 in Biological Psychiatry
Verified
Journal Article
Open access
GAGeorge S. Alexopoulos
George S. Alexopoulos
RARobert C. Abrams
Robert C. Abrams
RYRobert C. Young
Robert C. Young
CSCharles A. Shamoian
Charles A. Shamoian
The Cornell Scale for Depression in Dementia is introduced. This is a 19-item clinician-administered instrument that uses information from interviews with both the patient and a nursing staff member, a method suitable for demented patients. The scale has high interrater reliability (kw = 0.67), internal consistency (coefficient alpha: 0.84), and sensitivity. Total Cornell Scale scores correlate (0.83) with depressive subtypes of various intensity classified according to Research Diagnostic Criteria.

1 June 2005 in The Lancet
Verified
Journal Article
Closed access
GAGeorge S Alexopoulos
George S Alexopoulos

1 October 1997 in Archives of General Psychiatry
Verified
Journal Article
Closed access
PDF file
GAGeorge S. Alexopoulos
George S. Alexopoulos
BMBarnett S. Meyers
Barnett S. Meyers
RYRobert C. Young
Robert C. Young
SCScott Campbell
Scott Campbell
DSDavid Silbersweig
David Silbersweig
MCMary Charlson
Mary Charlson
We propose that cerebrovascular disease may predispose, precipitate, or perpetuate some geriatric depressive syndromes. The "vascular depression" hypothesis is supported by the comorbidity of depression, vascular disease, and vascular risk factors and the association of ischemic lesions to distinctive behavioral symptoms. Disruption of prefrontal systems or their modulating pathways by single lesions or by an accumulation of lesions exceeding a threshold are hypothesized to be central mechanisms in vascular depression. The vascular depression concept can generate studies of clinical and heuristic value. Drugs used for the prevention and treatment of cerebrovascular disease may be shown to reduce the risk for vascular depression or improve its outcomes. The choice of antidepressants in vascular depression may depend on their effect on neurologic recovery from ischemic lesions. Research can clarify the pathways to vascular depression by focusing on the site of the lesion, the resultant brain dysfunction, the presentation of depression and time of onset, and the contribution of nonbiological factors.

3 March 2004 in JAMA
Verified
Journal Article
Open access
PDF file
MBMartha L. Bruce
Martha L. Bruce
THThomas R. Ten Have
Thomas R. Ten Have
CICharles F. Reynolds Iii
Charles F. Reynolds Iii
IKIra I. Katz
Ira I. Katz
HSHerbert C. Schulberg
Herbert C. Schulberg
GAGeorge S. Alexopoulos
George S. Alexopoulos
Research from JAMA — Reducing Suicidal Ideation and Depressive Symptoms in Depressed Older Primary Care Patients — A Randomized Controlled Trial — ContextSuicide rates are highest in late life; the majority of older adults who die by suicide have seen a primary care physician in preceding months. Depression is the strongest risk factor for late-life suicide and for suicide's precursor, suicidal ideation.ObjectiveTo determine the effect of a primary care intervention on suicidal ideation and depression in older patients.Design and SettingRandomized controlled trial known as PROSPECT (Prevention of Suicide in Primary Care Elderly: Collaborative Trial) with patient recruitment from 20 primary care practices in New York City, Philadelphia, and Pittsburgh regions, May 1999 through August 2001.ParticipantsTwo-stage, age-stratified (60-74, ≥75 years) depression screening of randomly sampled patients; enrollment included patients who screened positive and a random sample of screened negative patients. This analysis included patients with a depression diagnosis (N = 598).InterventionTreatment guidelines tailored for the elderly with care management compared with usual care.Main Outcome MeasuresAssessment of suicidal ideation and depression severity at baseline, 4 months, 8 months, and 12 months.ResultsRates of suicidal ideation declined faster (P = .01) in intervention patients compared with usual care patients; at 4 months, in the intervention group, raw rates of suicidal ideation declined 12.9% points (29.4% to 16.5%) compared with 3.0% points (20.1% to 17.1% in usual care [P = .01]). Among patients reporting suicidal ideation, resolution of ideation was faster among intervention patients (P = .03); differences peaked at 8 months (70.7% vs 43.9% resolution; P = .005). Intervention patients had a more favorable course of depression in both degree and speed of symptom reduction; group difference peaked at 4 months. The effects on depression were not significant among patients with minor depression unless suicidal ideation was present.ConclusionsEvidence of the intervention's effectiveness in community-based primary care with a heterogeneous sample of depressed patients introduces new challenges related to its sustainability and dissemination. The intervention's effectiveness in reducing suicidal ideation, regardless of depression severity, reinforces its role as a prevention strategy to reduce risk factors for suicide in late life.

26 February 2013 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
WTW D Taylor
W D Taylor
HAH J Aizenstein
H J Aizenstein
GAG S Alexopoulos
G S Alexopoulos
The ‘Vascular Depression’ hypothesis posits that cerebrovascular disease may predispose, precipitate or perpetuate some geriatric depressive syndromes. This hypothesis stimulated much research that has improved our understanding of the complex relationships between late-life depression (LLD), vascular risk factors, and cognition. Succinctly, there are well-established relationships between LLD, vascular risk factors and cerebral hyperintensities, the radiological hallmark of vascular depression. Cognitive dysfunction is common in LLD, particularly executive dysfunction, a finding predictive of poor antidepressant response. Over time, progression of hyperintensities and cognitive deficits predicts a poor course of depression and may reflect underlying worsening of vascular disease. This work laid the foundation for examining the mechanisms by which vascular disease influences brain circuits and influences the development and course of depression. We review data testing the vascular depression hypothesis with a focus on identifying potential underlying vascular mechanisms. We propose a disconnection hypothesis, wherein focal vascular damage and white matter lesion location is a crucial factor, influencing neural connectivity that contributes to clinical symptomatology. We also propose inflammatory and hypoperfusion hypotheses, concepts that link underlying vascular processes with adverse effects on brain function that influence the development of depression. Testing such hypotheses will not only inform the relationship between vascular disease and depression, but also provide guidance on the potential repurposing of pharmacological agents that may improve LLD outcomes.

1 December 2001 in Psychiatric Services
Verified
Journal Article
Closed access
PDF file
JSJo Anne Sirey
Jo Anne Sirey
MBMartha L. Bruce
Martha L. Bruce
GAGeorge S. Alexopoulos
George S. Alexopoulos
DPDeborah A. Perlick
Deborah A. Perlick
SFSteven J. Friedman
Steven J. Friedman
BMBarnett S. Meyers
Barnett S. Meyers